Abstract
Background/Objectives:
Obesity is characterized by chronic inflammation and immune dysregulation, as well as insulin resistance, but the link between obesity and adaptive immunity remains to be fully studied.
Methods:
To elucidate the role of adaptive immunity on body composition, glucose homeostasis and inflammation, recombination-activating gene 1 knockout (Rag1−/−) mice, without mature T-lymphocytes or B-lymphocytes, were maintained on a low- or high-fat diet (LFD and HFD, respectively) for 11 weeks.
Results:
Rag1−/− mice fed HFD gained significantly more weight and had increased body fat compared with wild type. Downregulation of energy expenditure as well as brown fat uncoupling protein UCP-1 and UCP-3 gene expression were noticed in HFD-fed Rag1−/− mice compared with LFD. HFD mice had significantly decreased energy intake compared with LFD mice, consistent with decreased agouti-related protein and increased pro-opiomelanocortin gene expression levels in the hypothalamus. Moreover, compared with wild type, Rag1−/− mice had lower interleukin (IL)-4 levels, a cytokine recently found to induce browning in white adipocytes, and higher IL-12 levels in HFD-fed Rag1−/− mice. Despite that HFD Rag1−/− mice were more obese, they had similar glucose, insulin and adiponectin levels, while leptin was marginally increased.
Conclusions:
Mice with deficiency in adaptive immunity are obese, partly owing to decreased energy expenditure, but are metabolically normal, suggesting that mature lymphocytes have necessary roles in the development of obesity-related metabolic dysregulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689.
Lumeng CN, Saltiel AR . Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121: 2111–2117.
Michaud A, Boulet MM, Veilleux A, Noel S, Paris G, Tchernof A . Abdominal subcutaneous and omental adipocyte morphology and its relation to gene expression, lipolysis and adipocytokine levels in women. Metabolism 2014; 63: 372–381.
van Beek L, Lips MA, Visser A, Pijl H, Ioan-Facsinay A, Toes R et al. Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism 2014; 63: 492–501.
Lee BC, Lee J . Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta 2014; 1842: 446–462.
Odegaard JI, Chawla A . Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013; 339: 172–177.
Olefsky JM, Glass CK . Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010; 72: 219–246.
Aroor AR, McKarns S, Demarco VG, Jia G, Sowers JR . Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism 2013; 62: 1543–1552.
Nieman DC, Henson DA, Nehlsen-Cannarella SL, Ekkens M, Utter AC, Butterworth DE et al. Influence of obesity on immune function. J Am Diet Assoc 1999; 99: 294–299.
Krinninger P, Ensenauer R, Ehlers K, Rauh K, Stoll J, Krauss-Etschmann S et al. Peripheral monocytes of obese women display increased chemokine receptor expression and migration capacity. J Clin Endocrinol Metab 2014; 99: 2500–2509.
Mraz M, Haluzik M . The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 2014; 222: R113–R127.
Cildir G, Akincilar SC, Tergaonkar V . Chronic adipose tissue inflammation: all immune cells on the stage. Trends Mol Med 2013; 19: 487–500.
Patel PS, Buras ED, Balasubramanyam A . The role of the immune system in obesity and insulin resistance. J Obes 2013; 2013: 616193.
Lumeng CN, Bodzin JL, Saltiel AR . Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175–184.
Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE . RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992; 68: 869–877.
Bluher S, Moschos S, Bullen J Jr, Kokkotou E, Maratos-Flier E, Wiegand SJ et al. Ciliary neurotrophic factorAx15 alters energy homeostasis, decreases body weight, and improves metabolic control in diet-induced obese and UCP1-DTA mice. Diabetes 2004; 53: 2787–2796.
Lee DH, Huang H, Choi K, Mantzoros C, Kim YB . Selective PPARgamma modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice. Am J Physiol Endocrinol Metab 2012; 302: E552–E560.
Hausberg M, Morgan DA, Mitchell JL, Sivitz WI, Mark AL, Haynes WG . Leptin potentiates thermogenic sympathetic responses to hypothermia: a receptor-mediated effect. Diabetes 2002; 51: 2434–2440.
Nguyen AD, Herzog H, Sainsbury A . Neuropeptide Y and peptide YY: important regulators of energy metabolism. Curr Opin Endocrinol Diabetes Obes 2011; 18: 56–60.
Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15: 921–929.
Duffaut C, Galitzky J, Lafontan M, Bouloumie A . Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun 2009; 384: 482–485.
Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 1996; 26: 659–668.
Suarez-Alvarez K, Solis-Lozano L, Leon-Cabrera S, Gonzalez-Chavez A, Gomez-Hernandez G, Quinones-Alvarez MS et al. Serum IL-12 is increased in Mexican obese subjects and associated with low-grade inflammation and obesity-related parameters. Mediators Inflamm 2013; 2013: 967067.
Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H et al. Adaptive immune cells temper initial innate responses. Nat Med 2007; 13: 1248–1252.
Morris SC, Lees A, Finkelman FD . In vivo activation of naive T cells by antigen-presenting B cells. J Immunol 1994; 152: 3777–3785.
Brown MA . IL-4 production by T cells: you need a little to get a lot. J Immunol 2008; 181: 2941–2942.
Chang YH, Ho KT, Lu SH, Huang CN, Shiau MY . Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4. Int J Obes (Lond) 2012; 36: 993–998.
Ricardo-Gonzalez RR, Red Eagle A, Odegaard JI, Jouihan H, Morel CR, Heredia JE et al. IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity. Proc Natl Acad Sci USA 2010; 107: 22617–22622.
Qiu Y, Nguyen KD, Odegaard JI, Cui X, Tian X, Locksley RM et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014; 157: 1292–1308.
Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 2014; 157: 1279–1291.
Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971–981.
Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011; 34: 210–215.
Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A . Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care 2013; 36: 2294–2300.
Kramer CK, Zinman B, Retnakaran R . Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med 2013; 159: 758–769.
Acknowledgements
This work was conducted with support from Harvard Catalyst/The Harvard Clinical and Translational Science Center (NIH Award no. UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health-care centers), a discretionary grant from Beth Israel Deaconess Medical Center and award number 1I01CX000422-01A1 from the Clinical Science Research and Development Service of the VA Office of Research and Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health-care centers, the National Center for Research Resources or the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on International Journal of Obesity website
Rights and permissions
About this article
Cite this article
Liu, X., Huh, J., Gong, H. et al. Lack of mature lymphocytes results in obese but metabolically healthy mice when fed a high-fat diet. Int J Obes 39, 1548–1557 (2015). https://doi.org/10.1038/ijo.2015.93
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2015.93
This article is cited by
-
Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer
Cancer Cell International (2023)
-
Healthy adiposity and extended lifespan in obese mice fed a diet supplemented with a polyphenol-rich plant extract
Scientific Reports (2019)
-
Insights from engraftable immunodeficient mouse models of hyperinsulinaemia
Scientific Reports (2017)
-
Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia
Oncogene (2017)